Skip to Main Content

Paper Details

A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer.
Mol Oncol
31
2015
11q, 17q, 21-gene, 21-gene predictors, 70-gene, 70-gene signatures, Breast cancer, CAAI, DNA copy, ER, ER+ and ER- breast cancer, breast and ovarian cancer, breast cancer, breast cancers, breast carcinomas, cancer, cancer genomes, chromosome 8p, estrogen, estrogen receptor, expression, high, high-grade serous ovarian carcinomas, ovarian cancer, ovarian cancers, serous ovarian cancer, tumors
Author NameAffiliation
Hans Kristian Moen VollanCambridge Institute, University of Cambridge, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Norway The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo
Oscar M RuedaCambridge Institute, University of Cambridge
Christina CurtisKeck School of Medicine, University of Southern California
Sohrab P ShahUniversity of British Colombia, British Colombia Cancer Research Center
Ole Christian Lingj??rdeThe K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Norway Center for Cancer Biomedicine
Charlotte K Y NgMemorial Sloan-Kettering Cancer Center
Mark J DunningCambridge Institute, University of Cambridge
Stephen-John SammutAddenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre
Vessela N KristensenInstitute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Norway The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Akershus University Hospital
James D BrentonCambridge Institute, University of Cambridge, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre
Paul D P PharoahUniversity of Cambridge, UK Strangeways Research Laboratories, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre
Paul D P PharoahUniversity of Cambridge, UK Strangeways Research Laboratories, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre
Anne-Lise B??rresen-DaleInstitute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Norway The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo
Anne-Lise B??rresen-DaleInstitute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Norway The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo
Samuel AparicioUniversity of British Colombia, British Colombia Cancer Research Center
Carlos CaldasCambridge Institute, University of Cambridge, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre
  • 1 - 16

Datasets